|
๐
|
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
20 auth.
J. Baselga,
V. Semiglazov,
P. V. van Dam,
A. Manikhas,
M. Bellet,
J. Mayordomo,
M. Campone,
E. Kubista,
R. Greil,
G. Bianchi,
...
J. Steinseifer,
B. Molloy,
E. Tokaji,
H. Gardner,
P. Phillips,
M. Stumm,
H. Lane,
J. Dixon,
W. Jonat,
H. Rugo
|
9 |
2009 |
9
๐
|
|
๐
|
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
10 auth.
M. Schindl,
S. Schoppmann,
H. Samonigg,
H. Hausmaninger,
W. Kwasny,
M. Gnant,
...
R. Jakesz,
E. Kubista,
P. Birner,
G. Oberhuber
|
8 |
2002 |
8
๐
|
|
๐
|
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
20 auth.
M. Gnant,
B. Mlineritsch,
G. Luschin-Ebengreuth,
F. Kainberger,
H. Kรคssmann,
J. Piswanger-Sรถlkner,
M. Seifert,
F. Ploner,
C. Menzel,
P. Dubsky,
...
F. Fitzal,
V. Bjelic-Radisic,
G. Steger,
R. Greil,
C. Marth,
E. Kubista,
H. Samonigg,
P. Wohlmuth,
M. Mittlbรถck,
R. Jakesz
|
8 |
2008 |
8
๐
|
|
๐
|
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
14 auth.
R. Jakesz,
R. Greil,
M. Gnant,
M. Schmid,
W. Kwasny,
E. Kubista,
B. Mlineritsch,
C. Tausch,
M. Stierer,
F. Hofbauer,
...
K. Renner,
C. Dadak,
E. Ruecklinger,
H. Samonigg
|
8 |
2007 |
8
๐
|
|
๐
|
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
13 auth.
P. Kenemans,
N. Bundred,
J. Foidart,
E. Kubista,
B. V. VON Schoultz,
P. Sismondi,
R. Vassilopoulou-sellin,
C. Yip,
J. Egberts,
M. Mol-Arts,
...
Roel Mulder,
S. van Os,
M. Beckmann
|
8 |
2009 |
8
๐
|
|
๐
|
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
15 auth.
R. Jakesz,
H. Hausmaninger,
E. Kubista,
M. Gnant,
C. Menzel,
T. Bauernhofer,
M. Seifert,
K. Haider,
B. Mlineritsch,
P. Steindorfer,
...
W. Kwasny,
M. Fridrik,
G. Steger,
V. Wette,
H. Samonigg
|
8 |
2002 |
8
๐
|
|
๐
|
Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer
12 auth.
S. Schoppmann,
G. Bayer,
K. Aumayr,
S. Taucher,
S. Geleff,
M. Rudas,
...
E. Kubista,
H. Hausmaninger,
H. Samonigg,
M. Gnant,
R. Jakesz,
R. Horvat
|
8 |
2004 |
8
๐
|
|
๐ฌ
|
Circulating breast cancer cells are frequently apoptotic.
G. Mรฉhes,
A. Witt,
E. Kubista,
P. Ambros
|
7 |
2001 |
7
๐ฌ
|
|
๐
|
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
13 auth.
S. Amatschek,
Ulrich Koenig,
H. Auer,
P. Steinlein,
M. Pacher,
Agnes Gruenfelder,
G. Dekan,
Sonja Vogl,
E. Kubista,
K. Heider,
...
C. Stratowa,
M. Schreiber,
W. Sommergruber
|
7 |
2004 |
7
๐
|
|
๐
|
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.
18 auth.
J. Huober,
J. Huober,
P. Fasching,
P. Fasching,
M. Barsoum,
L. Petruลพelka,
D. Wallwiener,
C. Thomssen,
T. Reimer,
S. Paepke,
...
H. Azim,
V. Ragosch,
E. Kubista,
A. K. Baumgรคrtner,
M. Beckmann,
C. May,
I. Nimmrich,
N. Harbeck
|
7 |
2012 |
7
๐
|
|
๐
|
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
7 auth.
G. Hudelist,
M. Manavi,
K. Pischinger,
T. Watkins-Riedel,
C. Singer,
E. Kubista,
...
K. Czerwenka
|
7 |
2004 |
7
๐
|
